The Stem Cell Research Newswire: Comprehensive Real-Time News Feed for Stem Cell Research
Saturday, August 23, 2014
Viacyte Partners with Janssen on Diabetes Therapy
San Diego's ViaCyte has received $20 million from a drug company to advance its stem cell-based therapy for Type 1 diabetes into human clinical trials.
No comments:
Post a Comment